13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001922318
Total reported value
$1.4B
$1.4B
47 檔
47.6%
During the Q2 2024 filing period, Pale Fire Capital SE (CIK: 0001922318) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $1.4B across 47 reported positions.
During Q2 2024, Pale Fire Capital SE's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | T | At&t Inc | Stock-Comm Services | 22.58% | +1.67% | NEW | |
| 2 | SHEL | Shell Plc-adr | Stock-Energy | 18.00% | — | -16.25% | |
| 3 | GRPN | Groupon Inc | Stock-Other | 17.56% | +6.67% | — | |
| 4 | DOLE | Dole plc | Stock-Other | 11.31% | -2.69% | +6.91% | |
| 5 | INSW | International Seaways, Inc. | Stock-Other | 6.38% | — | -25.36% | |
| 6 | BTG | B2gold CORP | Stock-Other | 5.88% | -10.69% | — | |
| 7 | NMM | Navios Maritime Partners L.P. | Stock-Other | 3.97% | — | -1.70% | |
| 8 | STNG | Scorpio Tankers Inc. | Stock-Other | 3.29% | — | -40.71% | |
| 9 | CGAU | Centerra Gold Inc | Stock-Other | 2.16% | — | -4.11% | |
| 10 | TEN | Tsakos Energy Navigation Limited | Stock-Other | 1.67% | — | -4.08% | |
| 11 | ANGI1EUR | Angi Inc | Stock-Other | 1.39% | — | +7.13% | |
| 12 | TDOC | Teladoc Health Inc | Stock-Healthcare | 1.18% | -0.45% | +39.11% | |
| 13 | NE | Noble Corporation plc | Stock-Energy | 0.94% | — | — | |
| 14 | DAR | Darling Ingredients Inc | Stock-Consumer Staples | 0.56% | — | — | |
| 15 | NOMD | Nomad Foods Limited | Stock-Other | 0.48% | — | -38.44% | |
| 16 | DO1USD | Diamond Offshore Drilling In | Stock-Other | 0.44% | — | — | |
| 17 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 0.37% | — | — | |
| 18 | CAH | Cardinal Health Inc | Stock-Healthcare | 0.29% | — | — | |
| 19 | LUMN | Lumen Technologies Inc | Stock-Comm Services | 0.29% | — | — | |
| 20 | ORANY | Orange-spon Adr | Stock-Other | 0.28% | — | — | |
| 21 | DHC | Diversified Healthcare Trust | Stock-Other | 0.22% | — | +23.85% | |
| 22 | TNK | Teekay Tankers Ltd. | Stock-Other | 0.20% | — | -85.61% | |
| 23 | ✓ | Stock-Other | 0.13% | — | — | ||
| 24 | CDLR | Cadeler A/s-adr | Stock-Other | 0.08% | — | -75.56% | |
| 25 | IAUX | I-80 Gold CORP | Stock-Other | 0.05% | -0.86% | — | |
| 26 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.05% | +0.30% | +20.66% | |
| 27 | QURE | uniQure N.V. | Stock-Other | 0.03% | — | — | |
| 28 | MNKD | Mannkind CORP | Stock-Other | 0.02% | — | — | |
| 29 | CELC | Celcuity Inc | Stock-Other | 0.02% | — | +13.48% | |
| 30 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.02% | — | +15.74% | |
| 31 | ✓ | Inozyme Pharma Inc | Stock-Other | 0.02% | — | — | |
| 32 | CMRXEUR | Chimerix Inc | Stock-Other | 0.02% | — | +58.60% | |
| 33 | ✓ | Immatics NV | Stock-Other | 0.02% | -0.01% | EXIT | |
| 34 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 35 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 0.01% | — | +33.64% | |
| 36 | RNW | ReNew Energy Global Plc | Stock-Other | 0.01% | — | -74.99% | |
| 37 | LRMR | Larimar Therapeutics Inc | Stock-Other | 0.01% | +0.01% | NEW | |
| 38 | ASNSUSD | X4 Pharmaceuticals Inc | Stock-Other | 0.01% | — | +365.07% | |
| 39 | AVXL | Anavex Life Sciences CORP | Stock-Other | 0.01% | — | — | |
| 40 | CMPX | Compass Therapeutics Inc | Stock-Other | 0.01% | — | -34.29% | |
| 41 | ODV | Osisko Development CORP | Stock-Other | 0.01% | — | — | |
| 42 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.01% | — | +80.22% | |
| 43 | RVNCEUR | Revance Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 44 | ✓ | Rapt Therapeutics Inc | Stock-Other | 0.01% | — | — | |
| 45 | LYG | Lloyds Banking Group Plc-adr | Stock-Financials | — | — | — | |
| 46 | ATAI | AtaiBeckley Inc. | Stock-Other | — | — | — | |
| 47 | ✓ | Reviva Pharmaceutcls Hldgs I | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Pale Fire Capital SE reported a total U.S. public equity portfolio value of $1.4B across 47 disclosed positions in Q2 2024.
During Q2 2024, Pale Fire Capital SE's top holdings by market value included T (22.6%)、SHEL (18.0%)、GRPN (17.6%). The largest single position, T, represented 22.6% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including T, SHEL, GRPN) accounted for 47.6% of total reported equity market value during Q2 2024.
In Q2 2024, Pale Fire Capital SE made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.